Publications

cemka > Publications

Classer les publications sur l'année

  • Pharmaco-EpidĂ©miologie

    Instauration de l’insulinothĂ©rapie chez les diabĂ©tiques de type 2 en France : donnĂ©es de l’Ă©tude INSTIGATE

    CHARLES MA, CHARTIER F, BONNARD C, SMITH H, FAGNANI F, SALAUN-MARTIN C

    MĂ©decine des Maladies MĂ©taboliques ; 2011;5(2):189-198

  • Pharmaco-EpidĂ©miologie

    Five-year extension of a clinical trial comparing the EX-PRESS glaucoma filtration device and trabeculectomy in primary open-angle glaucoma

    DE JONG L, LAFUMA A, AGUADE AS, BERDEAUX G

    Clin Ophtalmol ; 2011;5:527-533

  • Epidemiology of atrial fibrillation in France : extrapolation of international epidemiological data to France and analysis of french hospitalization data

    CHARLEMAGNE A, BLACHER J, COHEN A, COLLET JP, DIEVART F, DE GROOTE P, HANON O, LEENARDT A, PINEL JF, PISICA-DONOSE G, LE HEUZEY JY

    Arch Cardiovasc Dis ; 2011;104:115-124

  • Économie de la santĂ©

    Economic impact of use of chlorhexidine-impregnated sponge dressing for prevention of central line-associated infections in the United States

    YE X, RUPNOW M, BASTIDE P, LAFUMA A, OVINGTON L, JARVIS WR

    Am J Infect Control ; 2011;39(8):647-654

  • Pharmaco-EpidĂ©miologie

    Do two intravenous iron sucrose preparations have the same efficacy ?

    ROTTEMBOURG J, KADRI A, LEONARD E, DANSAERT A, LAFUMA A

    2011 - Nephrol Dial Transplant ; 26 - 10 : 3262-3267

  • Économie de la santĂ©

    Cost effectivenessof posaconazole in the prophylaxis of invasive fungal infections in acute leukaemia patients for theFrench healthcare system

    MICHALLET M, GANGNEUX JP, LAFUMA A, HERBRECHT R, RIBAUD P, CAILLOT D, DUPONT B, MOREAU P, BERGER P, O’SULLIVAN AK

    J Med Econ ; 2011;14(1):28-35

  • Comparison of outcomes with multifocal intraocular lenses : A meta-analysis

    COCHENER B, LAFUMA A, KHOSHNOOD B, COUROUVE L, BERDEAUX G

    Clin Ophtalmol ; 2011;5:45-56

  • Pharmaco-EpidĂ©miologie

    Biomechanical and psychosocial work exposures and musculoskeletal symptoms among vineyard workers

    BERNARD C, COUROUVE L, BOUEE S, ADJEMIAN A, CHRETIEN JC, NIEDHAMMER I

    J Occup Health ; 2011;53:297-311

  • Pharmaco-EpidĂ©miologie

    Type 2 diabetes treatment intensification in general practice in France in 2008-2009 : the DIAttitude Study

    BALKAU B, BOUEE S, AVIGNON A, VERGES B, CHARTIER I, AMELINEAU E, HALIMI S

    Diabetes Metab ; 2012;38:29-35

  • Pharmaco-EpidĂ©miologie

    Therapeutic management of orally treated type 2 diabetic patients, by French general practitioners in 2010 : the DIAttitude Study

    HALIMI S, BALKAU B, ATTALI C, DETOURNAY B, AMELINEAU E, BLICKLE JF

    Diabetes Metab ; 2012;38:36-46

  • Pharmaco-EpidĂ©miologie

    Prise en charge du purpura thrombopénique immunologique en France avant la mise à disposition des agonistes du récepteur à la thrombopoïétine

    MICHEL M, DOZ M, LECLERC-TEFFAHI S, DETOURNAY B, LEVY-BACHELOT L

    Rev Med Interne ; 2012;33:305–310

  • Pharmaco-EpidĂ©miologie

    Pegylated interferon-α2a plus ribavirin for chronic hepatitis C in a real-life setting: the Hepatys French cohort (2003-2007)

    BOURLIERE M, OUZAN D, ROSENHEIM M, DOFFOËL M, MARCELLIN P, PAWLOTSKY JM, SALOMON L, FAGNANI F, ROUANET S, PINTA A, VRAY M
    SALOMON L, FAGNANI F, ROUANET S, PINTA A, VRAY M

    Antivir Ther ; 2012;17(1):101-110

  • Économie de la santĂ©

    Long term treatment of atrial fibrillation in elderly patients: A decision analysis

    LAFUENTE C, EMERY C, LAURENDEAU C, FAGNANI F, BERGMANN JF

    Int J Cardiol ; 2012;155(1):102-109

  • Économie de la santĂ©

    L’investissement industriel en recherche clinique Ă  l’hĂŽpital : une estimation pour la France en 2010

    FAGNANI F

    Thérapie ; 2012;67(2):89-96

  • Économie de la santĂ©

    L’Ă©valuation mĂ©dico-Ă©conomique : une place qui reste Ă  trouver


    DETOURNAY B

    La Lettre du CollĂšge ; 2012;2:5-7